Tilray (NASDAQ:TLRY) stock is on the move Monday as investors in the cannabis company react to it securing a trading license in Germany for its Aphria RX subsidiary.With this trading license, Aphria RX is now able to sell and distribute medical cannabis products to a wide range of locations. That includes pharmacies, hospitals, and medical wholesalers in Germany.Investors will note that this builds on the cannabis cultivation license that Tilray already has in Germany. This gives it a strong foothold in the ...